Effect of hematocrit on blood pressure via hyperviscosity.

Increase in blood viscosity, defined as resistance to flow, is one factor in hypertension and atherosclerosis that contributes to the morbidity and mortality associated with tissue ischemia. In this research we evaluated the effect of hematocrit on increasing viscosity, and possible related changes in blood pressure, flow rate, and the equivalent physiologic compensation ratios. Blood samples were taken from 32 healthy individuals and centrifuged for 5 min at 3000 rpm to obtain 2.5 mL of erythrocyte mass from each. Then, at each step 0.5 mL of plasma was consecutively added in a total of 17 steps. The resultant hematocrit and viscosity changes were measured. Viscosity measurement was performed by capillary viscometer. The results were evaluated by the Student t test. It was observed that in the range of 60.16% and 25.32%, a 10.99% increase of hematocrit produced an increase of 1 unit relative viscosity, which means approximately a 20% increase in blood viscosity for a healthy individual. According to Poiseuille's equation, with a constant vessel length, if viscosity is increased by 20%, the decrease in blood flow rate will be 16.67% (100/120 = 83.33%; 100 - 83.33 = 16.67%). For the physiologic compensation of 20% increased viscosity, blood pressure increase will be 20% or vasodilation will be 4.66% in radius. Atherosclerotic and some healthy vessels with little vasodilatory capacities might benefit from treatment modalities to decrease the viscosity by hemodilution.

[1]  D. J. Cole,et al.  Hypervolemic-hemodilution during cerebral ischemia in rats: effect of diaspirin cross-linked hemoglobin (DCLHb) on neurologic outcome and infarct volume. , 1997, Journal of neurosurgical anesthesiology.

[2]  S. Vatner,et al.  Reactive Dilation of Large Coronary Arteries in Conscious Dogs , 1984, Circulation research.

[3]  J. Agmon,et al.  Plasma viscosity in ischemic heart disease. , 1984, American heart journal.

[4]  R. Mueller,et al.  On the Therapy of Disturbances of Blood Fluidity , 1985, Angiology.

[5]  D. Costa,et al.  Polycythaemia and agoraphobia. , 1996, Journal of behavior therapy and experimental psychiatry.

[6]  J. Fahey,et al.  SERUM HYPERVISCOSITY SYNDROME. , 1965, JAMA.

[7]  J. D. Marx,et al.  Analysis of Coronary Responses to Various Doses of Intracoronary Nitroglycerin , 1982, Circulation.

[8]  Michael V. Green,et al.  Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. , 1985, Circulation.

[9]  M. Leon,et al.  Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. , 1987, Circulation.

[10]  Hoffman Ji A critical view of coronary reserve. , 1987, Circulation.

[11]  N. Ketley Wintrobe's Clinical Hematology , 1992 .

[12]  W. Koenig,et al.  Association between plasma viscosity and blood pressure. Results from the MONICA-project Augsburg. , 1991, American journal of hypertension.

[13]  B. Vojniković Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma. , 1991, Ophthalmic research.

[14]  B. Barlogie,et al.  Plasma cell dyscrasias. , 1992, JAMA.

[15]  M. Rappaport,et al.  The acute effect of sublingual nifedipine and isosorbide dinitrate on plasma viscosity in patients with acute myocardial infarction , 1986, Clinical cardiology.

[16]  J. Laragh,et al.  Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. , 1984, The American journal of cardiology.

[17]  M. Marcus,et al.  Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. , 1982, The New England journal of medicine.

[18]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[19]  E. Schmid,et al.  Hemodilution Tolerance in Patients with Coronary Artery Disease Who Are Receiving Chronic beta-Adrenergic Blocker Therapy , 1996, Anesthesia and analgesia.

[20]  M. Shearn,et al.  Effect of Intravenous Heparin on Human Blood Viscosity , 1959, Circulation.